Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation.

Xia XZ, Treanor J, Senaldi G, Khare SD, Boone T, Kelley M, Theill LE, Colombero A, Solovyev I, Lee F, McCabe S, Elliott R, Miner K, Hawkins N, Guo J, Stolina M, Yu G, Wang J, Delaney J, Meng SY, Boyle WJ, Hsu H.

J Exp Med. 2000 Jul 3;192(1):137-43.

2.

The uncertain glory of APRIL.

Medema JP, Planelles-Carazo L, Hardenberg G, Hahne M.

Cell Death Differ. 2003 Oct;10(10):1121-5. Review.

3.
4.

Mechanism of BLyS action in B cell immunity.

Do RK, Chen-Kiang S.

Cytokine Growth Factor Rev. 2002 Feb;13(1):19-25. Review.

PMID:
11750877
5.

Molecular basis of common variable immunodeficiency.

Castigli E, Geha RS.

J Allergy Clin Immunol. 2006 Apr;117(4):740-6; quiz 747. Review.

PMID:
16630927
6.

Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency.

Lee JJ, Ozcan E, Rauter I, Geha RS.

Curr Opin Allergy Clin Immunol. 2008 Dec;8(6):520-6. doi: 10.1097/ACI.0b013e3283141200. Review.

PMID:
18978466
7.

[The role of BAFF in autoimmune diseases].

Matsushita T, Sato S.

Nihon Rinsho Meneki Gakkai Kaishi. 2005 Oct;28(5):333-42. Review. Japanese.

8.

A family of ligands for the TNF receptor superfamily.

Cosman D.

Stem Cells. 1994 Sep;12(5):440-55. Review.

PMID:
7528588
9.

The BAFF/APRIL system: life beyond B lymphocytes.

Ng LG, Mackay CR, Mackay F.

Mol Immunol. 2005 May;42(7):763-72. Epub 2004 Dec 8. Review.

PMID:
15829264
10.

TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties.

Mackay F, Schneider P.

Cytokine Growth Factor Rev. 2008 Jun-Aug;19(3-4):263-76. doi: 10.1016/j.cytogfr.2008.04.006. Epub 2008 Jun 2. Review.

PMID:
18514565
11.
12.

The TNF family members BAFF and APRIL: the growing complexity.

Mackay F, Ambrose C.

Cytokine Growth Factor Rev. 2003 Jun-Aug;14(3-4):311-24. Review.

PMID:
12787568
13.

Anti-CD137 antibodies in the treatment of autoimmune disease and cancer.

Mittler RS, Foell J, McCausland M, Strahotin S, Niu L, Bapat A, Hewes LB.

Immunol Res. 2004;29(1-3):197-208. Review.

PMID:
15181282
14.
15.
16.

The TNF ligand superfamily and its relevance for human diseases.

Gruss HJ, Dower SK.

Cytokines Mol Ther. 1995 Jun;1(2):75-105. Review.

PMID:
9384666
17.

Human B lymphocyte malignancies: exploitation of BLyS and APRIL and their receptors.

Jelinek DF, Darce JR.

Curr Dir Autoimmun. 2005;8:266-88. Review.

PMID:
15564725
18.

Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease.

Rickert RC, Jellusova J, Miletic AV.

Immunol Rev. 2011 Nov;244(1):115-33. doi: 10.1111/j.1600-065X.2011.01067.x. Review.

19.

B lymphocyte stimulator (BLyS): a therapeutic trichotomy for the treatment of B lymphocyte diseases.

Nardelli B, Moore PA, Li Y, Hilbert DM.

Leuk Lymphoma. 2002 Jul;43(7):1367-73. Review.

PMID:
12389615
20.

Apoptosis mediated by the TNF-related cytokine and receptor families.

Ware CF, VanArsdale S, VanArsdale TL.

J Cell Biochem. 1996 Jan;60(1):47-55. Review.

PMID:
8825415

Supplemental Content

Support Center